NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-221-1997-0-AT-09 CHIMERIC VACCINE AGAINST TICK-BORNE ENCEPHALITIS VIRUS AT EP 98952184.4 Abandoned
NIAID E-221-1997-0-RU-04 CHIMERIC VACCINE AGAINST TICK-BORNE ENCEPHALITIS VIRUS RU National Stage 20000107129/14 Abandoned
NIAID E-221-1997-0-PCT-02 CHIMERIC VACCINE AGAINST TICK-BORNE ENCEPHALITIS VIRUS PCT PCT PCT/US1998/021308 Expired
CC E-285-1998-0-US-01 Triplex Mediated Site Directed Mutagenesis US 60/103,546 Abandoned
NCI E-002-1999-0-US-01 Method of Reversing Resistance to Cisplatin Utilizing a Dominant- Negative construct US 60/103,330 Abandoned
NIMH E-178-1996-3-US-01 DELETION OF LYSOGENY GENES AND TOXIN GENES FROM BACTERIOPHAGE USED IN THE EPIDEMIOLOGIC CONTROL OF BACTERIAL ILLNESS US 60/103,035 Abandoned
NIMH E-178-1996-6-US-01 DELETION OF LYSOGENY GENES AND TOXIN GENES FROM BACTERIOPHAGE USED IN THE EPIDEMIOLOGIC CONTROL OF BACTERIAL ILLNESS US 60/103,034 Abandoned
NEI E-027-2000-0-US-02 Method For Ameliorating An Allergic Reaction US CON 09/167,039 Abandoned
NIDCR E-227-1998-0-US-01 Osteonectin related protein responsible for cancer cell metastasis to bone US 60/102,918 Abandoned
NIDDK E-289-1997-0-US-03 METHOD OF PREVENTING NEPHROTOXICITY CAUSED BY CYCLOSPORINS US ORD 09/168,974 6187745 Abandoned PDF
NCI E-088-1996-0-US-12 MUTATED RAS PEPTIDES FOR THE GENERATION OF CD8+ CYTOTOXIC T LYMPHOCYTES US National Stage 09/155,590 7709002 Abandoned PDF
NIA E-284-1998-0-US-01 Method of Using a Beta2-Adrenergic Receptor Agonist That Selectively Activates GS Proteins in the Treatment of Cardiovascular Disease US 60/102,475 Abandoned
NHLBI E-243-1998-0-US-01 Ultrasound Probes Implementing Waveguide Shielding and Active Compensation of Noise US 60/102,479 Abandoned
NHLBI E-093-1998-0-US-01 Ultrasound Array and Electrode Array for Hall Effect Imaging US 60/102,478 Abandoned
NHGRI E-212-1998-0-US-01 Ratio-Based Decisions and The Quantitative Analysis of cDNA Micro- Array Images US 60/102,365 Abandoned
NCI E-183-1996-0-US-02 IDENTIFICATION OF TRP-2 AS A NEW HUMAN TUMOR ANTIGEN RECOGNIZED BY CYTOTOXIC T LYMPHOCYTES US DIV 09/161,877 6132980 Expired PDF
NCI E-183-1996-0-US-03 IDENTIFICATION OF TRP-2 AS A NEW HUMAN TUMOR ANTIGEN RECOGNIZED BY CYTOTOXIC T LYMPHOCYTES US DIV 09/162,368 6083703 Expired PDF
NICHD E-085-1996-0-PCT-02 NUCLEOTIDE AND AMINO ACID SEQUENCES OF THE BRX GENE AND GENE PRODUCT, AND USES THEREOF PCT PCT PCT/US98/19782 Expired
NIDCR E-044-1998-0-US-01 Methods of Treating Chronic Pain US 60/100,901 Abandoned
NCI E-099-1996-0-CA-04 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) CA National Stage 2308127 Expired
NCI E-099-1996-0-JP-06 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) JP National Stage 2000-516030 Expired
NCI E-099-1996-0-ES-32 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) ES EP 04011673.3 Expired
NCI E-099-1996-0-SE-38 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) SE EP 04011673.3 Expired
NCI E-099-1996-0-PT-37 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) PT EP 04011673.3 Expired
NCI E-099-1996-0-EP-17 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) EP DIV 04011673.3 Expired
NCI E-099-1996-0-AT-28 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) AT EP 04011673.3 Expired
NCI E-099-1996-0-BE-29 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) BE EP 04011673.3 Expired
NCI E-099-1996-0-FR-42 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) FR EP 04011673.3 Expired
NCI E-099-1996-0-DE-40 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) DE EP 04011673.3 Expired
NCI E-099-1996-0-GR-34 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) GR EP 04011673.3 Expired
NCI E-099-1996-0-IE-35 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) IE EP 04011673.3 Expired
NCI E-099-1996-0-IT-36 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) IT EP 04011673.3 Expired
NCI E-099-1996-0-DK-41 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) DK EP 04011673.3 Expired
NCI E-099-1996-0-FI-33 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) FI EP 04011673.3 Expired
NCI E-099-1996-0-CY-31 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) CY EP 04011673.3 Expired
NCI E-099-1996-0-LU-44 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) LU EP 04011673.3 Expired
NCI E-099-1996-0-MC-45 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) MC EP 04011673.3 Expired
NCI E-099-1996-0-NL-46 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) NL EP 04011673.3 Expired
NCI E-099-1996-0-GB-43 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) GB EP 04011673.3 Expired
NCI E-099-1996-0-CH-30 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) CH EP 04011673.3 Expired
NCI E-099-1996-0-ES-13 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) ES EP 98948429.0 Expired
NCI E-099-1996-0-CH-14 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) CH EP 98948429.0 Expired
NCI E-099-1996-0-GB-11 Agonist and Antagonist Petide of Carcinoembryonic Antigen (CEA) GB EP 98948429.0 Expired
NCI E-099-1996-0-BE-15 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) BE EP 98948429.0 Expired
NCI E-099-1996-0-FR-10 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) FR EP 98948429.0 Expired
NCI E-099-1996-0-EP-05 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) EP National Stage 98948429.0 Expired
NCI E-099-1996-0-IT-12 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) IT EP 98948429.0 Expired
NCI E-099-1996-0-IE-16 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) IE EP 98948429.0 Expired
NCI E-099-1996-0-AU-03 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) AU National Stage 95004/98 Expired
NCI E-065-1996-2-US-24 ACRIDONE-DERIVED COMPOUNDS USEFUL AS ANTINEOPLASTIC AND ANTIRETROVIRAL AGENTS US National Stage 09/155,141 6187775 Abandoned PDF